“The efficacy and toxicity of programs MOPP, ABVD, BEACOPP-base in primary Hodgkin’s lymphoma patients with a poor prognosis” (2013) Voprosy onkologii, 59(2), pp. 59–65. doi:10.37469/0507-3758-2013-59-2-59-65.